行情

NYMX

NYMX

Nymox
NASDAQ

实时行情|Nasdaq Last Sale

1.810
-0.010
-0.55%
已收盘, 16:00 11/15 EST
开盘
1.845
昨收
1.820
最高
1.845
最低
1.800
成交量
2.04万
成交额
--
52周最高
2.750
52周最低
1.250
市值
1.24亿
市盈率(TTM)
-10.6122
分时
5日
1月
3月
1年
5年

NYMX 新闻

  • The Nymox Pharmaceutical (NASDAQ:NYMX) Share Price Is Up 172% And Shareholders Are Boasting About It
  • Simply Wall St..11/05 14:35
  • 锁定磋商成果,中美向阶段性协议再近一步
  • 央视.10/27 22:25
  • 网易有道上市之后
  • 新浪财经综合.10/27 21:48
  • SpaceX:将在之后三年左右实现“星舰”载人着陆月球
  • 新浪美股.10/27 21:32

更多

所属板块

生物技术和医学研究
+1.49%
制药与医学研究
+1.29%

热门股票

名称
价格
涨跌幅

NYMX 简况

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
展开

Webull提供Nymox Pharmaceutical Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。